Good Days Funding

Update for 2025


As of January 1, 2025, Good Days funding for Retina and Macular Disease is currently not available for many patients. 



  • For patients re-enrolled in 2025: Funding is unavailable at this time for many patients. You are responsible for any outstanding balances for your visits. We are unsure when, or if, funding will become available. Talk to your doctor about switching medications if paying the balance is not possible for you. 


  • For patients who have not yet re-enrolled: Please re-enroll as soon as possible at www.mygooddays.org/reenroll. If funding becomes available, re-enrollment is necessary to ensure you are eligible for assistance. 


  • Good Days is not accepting new enrollments at this time. 




  • For questions about the amount you are responsible for, contact your insurance company. Ask what your out-of-pocket maximum costs are for your plan and the amount you will owe on the drug. Provide the drug name and CPT code.
  • Eylea: J0178 
  • Eylea HD: J0177 
  • Ozurdex: J7312 
  • Syfovre: J2781 
  • Vabysmo: J2777P 
  • Izervay: J2782 
  • Cimerli: Q5128 


For questions about a prior balance owed, contact our Billing team at 216-831-5704. 


Access these websites by opening the camera app on your phone and pointing your device at these QR codes (one at a time). Click the pop-up command to open the link in your default browser. 


If you're reading this on your cell phone, click the words "Good Days" or "US Elected Officials".

Good Days

US Elected Officials